1. Home
  2. Author
  3. Drouot C

Drouot C

References (2)

Title : GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions - Brun_2022_Autophagy_18_678
Author(s) : Brun S , Bestion E , Raymond E , Bassissi F , Jilkova ZM , Mezouar S , Rachid M , Novello M , Tracz J , Hama A , Lalmanach G , Vanderlynden L , Legouffe R , Stauber J , Schubert T , Plach MG , Courcambeck J , Drouot C , Jacquemot G , Serdjebi C , Roth G , Baudoin JP , Ansaldi C , Decaens T , Halfon P
Ref : Autophagy , 18 :678 , 2022
Abstract :
PubMedSearch : Brun_2022_Autophagy_18_678
PubMedID: 34740311
Gene_locus related to this paper: human-PPT1

Title : Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis - Bordet_2007_J.Pharmacol.Exp.Ther_322_709
Author(s) : Bordet T , Buisson B , Michaud M , Drouot C , Galea P , Delaage P , Akentieva NP , Evers AS , Covey DF , Ostuni MA , Lacapere JJ , Massaad C , Schumacher M , Steidl EM , Maux D , Delaage M , Henderson CE , Pruss RM
Ref : Journal of Pharmacology & Experimental Therapeutics , 322 :709 , 2007
Abstract :
PubMedSearch : Bordet_2007_J.Pharmacol.Exp.Ther_322_709
PubMedID: 17496168